Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2024-02-28 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
益丰大药房连锁股份有限公司向不特定对象发行可转换公司债券信用评级报告
Audit Report / Information Classification · 95% confidence The document is titled "公司债券信用评级报告" which translates to "Corporate Bond Credit Rating Report." It is issued by a credit rating agency (联合资信评估股份有限公司) and provides a detailed credit rating analysis of the company 益丰大药房连锁股份有限公司 and its proposed convertible bonds issuance. The document includes detailed financial data, credit rating results, bond issuance terms, and industry and macroeconomic analysis. It is a comprehensive standalone credit rating report focused on the creditworthiness of the company and its bond issuance, not an annual report, earnings release, or other types of filings. This fits the definition of an Audit Report / Information (AR) as it is a standalone audit/credit rating report with applied methodologies and results. The document length (15,000 characters) and content confirm it is the report itself, not just an announcement or certification. Therefore, the appropriate classification is AR with high confidence. 9M 2023
2024-02-28 Chinese
益丰药房关于向不特定对象发行可转换公司债券发行公告
Capital/Financing Update Classification · 100% confidence The document is a detailed announcement regarding the issuance of convertible corporate bonds by 益丰大药房连锁股份有限公司. It includes extensive information about the bond issuance process, terms, subscription details, pricing, interest rates, redemption, and regulatory approvals. The document references regulatory bodies such as the China Securities Regulatory Commission and Shanghai Stock Exchange, and provides detailed issuance terms and investor instructions. This is a formal announcement of a capital raising event through convertible bonds, not a financial report, earnings release, or management discussion. It is not a brief summary or a report publication announcement but a comprehensive issuance announcement. Therefore, the document fits best into the category of Capital/Financing Update (CAP).
2024-02-28 Chinese
益丰药房第四届董事会第三十七次会议决议公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement of resolutions passed at a board meeting of 益丰大药房连锁股份有限公司 (Yifeng Pharmacy Chain Co., Ltd.). It includes specifics about the issuance of convertible bonds, such as issuance scale, interest rates, conversion period, initial conversion price, redemption terms, issuance method, and allotment arrangements. The document also references regulatory approval from the China Securities Regulatory Commission and mentions the company's board meeting procedures and voting results. The content focuses on financing activities, specifically the issuance of convertible bonds to unspecified investors, which is a capital raising event. The document is not a full financial report, audit, or earnings release, nor is it a simple announcement of a report publication. It is a detailed update on capital/financing activities, fitting the Capital/Financing Update (CAP) category.
2024-02-28 Chinese
益丰大药房连锁股份有限公司向不特定对象发行可转换公司债券募集说明书摘要
Capital/Financing Update Classification · 95% confidence The document is titled as a "募集说明书摘要" which translates to "Offering Circular Summary" or "Prospectus Summary" for a convertible bond issuance by Yifeng Pharmacy Chain Co., Ltd. It contains detailed information about the convertible bond issuance, including the nature of the bonds, credit rating, lack of guarantees, dividend policy, investment risks, and commitments by management and controlling shareholders. It also includes financial data related to the company's 2023 third quarter report but does not itself constitute a full quarterly or annual financial report. The document is a detailed offering prospectus related to capital raising through convertible bonds, which fits the category of Capital/Financing Update (CAP). It is not an Annual Report, Interim Report, or Earnings Release, nor is it a regulatory announcement or a proxy statement. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2024-02-28 Chinese
益丰大药房连锁股份有限公司向不特定对象发行可转换公司债券募集说明书
Capital/Financing Update Classification · 95% confidence The document is titled as a "募集说明书" which translates to a "Prospectus" or "Offering Circular" for the issuance of convertible bonds by Yifeng Pharmacy Chain Co., Ltd. It contains detailed information about the bond issuance, including the nature of the convertible bonds, credit ratings, risk factors, company background, financial data, and commitments by management and controlling shareholders. The document is comprehensive and lengthy (15,000 characters), indicating it is the full offering prospectus rather than a brief announcement or summary. This type of document is related to capital raising activities and financing updates. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2024-02-28 Chinese
益丰大药房连锁股份有限公司向不特定对象发行可转换公司债券网上路演公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding an online roadshow for a convertible bond issuance by 益丰药房 (Yifeng Pharmacy). It mentions the bond issuance has been approved by the China Securities Regulatory Commission and provides details about the roadshow event, including date, time, and participation. The document does not contain financial statements or detailed financial data but is clearly an update related to the company's capital raising activities. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is short and it is not a report publication announcement or regulatory filing. Confidence is high due to clear context and content.
2024-02-28 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.